Thor Medical ASA (TRMED.OL)
NOK 2.66
(1.92%)
NOK 2.66
(1.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | 7.16 Million | - | 442.43 Million | 434.16 Million |
| Selling, General and Administrative Expenses | 3.13 Million | 28.77 Million | 24.89 Million | 28.14 Million |
| Research and Development Expenses | 945 Thousand | - | 317.98 Million | 318.58 Million |
| Other Expenses | 3.08 Million | - | - | - |
| Cost and Expenses | 7.16 Million | - | 442.43 Million | 434.16 Million |
| Operating Income | -7.16 Million | - | -442.43 Million | -434.16 Million |
| Interest Expense | - | - | 414 Thousand | 471 Thousand |
| Income Tax Expense | 1000.00 | 311.24 Million | 1.16 Million | 914 Thousand |
| Earnings before Tax | -5.56 Million | - | -440.13 Million | -416.16 Million |
| Net Income | -26.56 Million | -311.24 Million | -441.3 Million | -417.07 Million |
| Earnings Per Share Basic | -0.03 | -2.70 | -4.65 | -5.92 |
| Earnings Per Share Diluted | -0.03 | -2.70 | -4.65 | -5.92 |
| Weighted Average Shares Outstanding | 174.78 Million | 115.12 Million | 94.81 Million | 70.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 174.78 Million | 115.12 Million | 94.81 Million | 70.48 Million |
| Gross Margin | - | - | - | - |
| EBIT Margin | - | - | - | - |
| Profit Margin | - | - | - | - |
| EBITDA | -6.82 Million | 11.2 Million | -428.35 Million | -400.79 Million |
| Earnings Before Tax Margin | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 6550.00 | 6550.00 | 7.16 Million | - | - | - |
| Selling, General and Administrative Expenses | 2250.00 | 2250.00 | - | - | - | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 4300.00 | 4300.00 | - | - | - | - |
| Cost and Expenses | 6550.00 | 6550.00 | 7.16 Million | - | - | - |
| Operating Income | -6550.00 | -6550.00 | -7.16 Million | -13.25 Thousand | -13.25 Thousand | - |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | - | 22.6 Million | 13.25 Thousand | 13.25 Thousand | 311.24 Million |
| Earnings before Tax | -6500.00 | -6500.00 | -5.56 Million | - | - | - |
| Net Income | -6500.00 | -6500.00 | -26.56 Million | -13.25 Thousand | -13.25 Thousand | -311.24 Million |
| Earnings Per Share Basic | - | -0.03 | - | -0.11 | -0.11 | - |
| Earnings Per Share Diluted | - | -0.03 | - | -0.11 | -0.11 | - |
| Weighted Average Shares Outstanding | 234.2 Million | 234.2 Million | 174.78 Million | 116 Million | 116 Million | 115.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 234.2 Million | 234.2 Million | 174.78 Million | 116 Million | 116 Million | 115.12 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -6350.00 | -6350.00 | - | -13.25 Thousand | -13.25 Thousand | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
UCOBANK
4513
3325
4510
1541
UFCS